Furthermore, silencing of FASN induced upregulation of the fatty acid transporter LPL and downregulation of the fatty acid transporter CD36 in the four human HCC cell lines (Figure 6, Figures S2–S4). Here, LPL is linked to hepatocellular carcinoma.